Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have been given a consensus rating of "Moderate Buy" by the ten brokerages that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $36.56.

SGRY has been the subject of a number of research analyst reports. Macquarie reiterated an "outperform" rating and issued a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. Royal Bank of Canada reduced their price target on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a report on Wednesday, November 20th. JPMorgan Chase & Co. decreased their price target on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research note on Tuesday, December 3rd. Finally, Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a "buy" rating and a $30.00 price objective for the company.

Surgery Partners Stock Down 2.2 %

NASDAQ:SGRY traded down $0.54 during mid-day trading on Thursday, reaching $24.08. The company's stock had a trading volume of 2,900,132 shares, compared to its average volume of 1,458,873. Surgery Partners has a 1 year low of $19.50 and a 1 year high of $33.97. The stock has a fifty day moving average of $23.04 and a 200-day moving average of $26.47. The firm has a market capitalization of $3.06 billion, a PE ratio of -50.17, a price-to-earnings-growth ratio of 19.21 and a beta of 2.60. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Remove Ads

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Harrison R. Bane sold 56,315 shares of the company's stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the transaction, the insider now directly owns 107,037 shares in the company, valued at $2,744,428.68. This represents a 34.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jason Eric Evans sold 26,520 shares of Surgery Partners stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.65, for a total value of $680,238.00. Following the completion of the sale, the chief executive officer now directly owns 560,698 shares of the company's stock, valued at $14,381,903.70. The trade was a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 96,733 shares of company stock valued at $2,480,106 over the last 90 days. 2.30% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

A number of institutional investors and hedge funds have recently bought and sold shares of SGRY. Principal Financial Group Inc. purchased a new position in shares of Surgery Partners in the third quarter valued at approximately $1,469,000. King Street Capital Management L.P. acquired a new position in shares of Surgery Partners in the third quarter worth $46,748,000. Royce & Associates LP increased its position in shares of Surgery Partners by 12.2% during the third quarter. Royce & Associates LP now owns 510,261 shares of the company's stock worth $16,451,000 after acquiring an additional 55,545 shares during the period. Geode Capital Management LLC increased its position in shares of Surgery Partners by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company's stock worth $60,117,000 after acquiring an additional 42,897 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of Surgery Partners by 140.4% in the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company's stock valued at $42,892,000 after acquiring an additional 777,038 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.